Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)

• Main Authors: Nan Shen (Author), Lihong Zhang (Author), Jing Yang (Author), Yongqiang Lin (Author), Xinyu Liu (Author), Xudong Cai (Author), Juan Cao (Author), Qiang Zhu (Author), Xun Luo (Author), Xin Wan (Author), Henglan Wu (Author), Jianming Ye (Author), Chunyan Shan (Author), Hua Xie (Author), Yifan Wu (Author), Yanping Cao (Author), Jianmin Wang (Author), Xiaoyong Yu (Author), Huimin Wang (Author), Jingdong He (Author), Shaojiang Tian (Author), Fenglei Wu (Author), Xinxin Jiang (Author), Lu Li (Author), Li Zuo (Author), Zhaohua Wang (Author), Changying Xing (Author), Xun Yin (Author), Jianrong Zhao (Author), Cong Ma (Author), Gang Long (Author), Qing Li (Author), Yao Hu (Author), Yifan Shi (Author), Hongli Lin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Sodium zirconium cyclosilicate (SZC) is a nonabsorbed cation-exchanger approved in China for the treatment of hyperkalemia [HK; serum potassium (sK+) levels >5.0 mmol/L]. This is the first real-world study aimed to assess the effectiveness, safety, and treatment patterns of SZC in C...